Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1628 1655
This examiner grants 35% of resolved cases
Jacob A. Boeckelman is an examiner in Tech Center 1600, working within Art Unit 1628. He has 253 resolved cases in his professional history. The data shows an allowance rate pct of 35.2, which indicates that a majority of the applications he examines do not result in a grant. This 35.2 allowance rate pct suggests a challenging environment for applicants in Art Unit 1628, where rejections are common.
However, the interview lift pct of 45.6 offers a clear strategic path for practitioners. This 45.6 interview lift pct indicates that engaging in a direct dialogue with Boeckelman significantly increases the likelihood of securing an allowance. Given the median days to allowance of 1151, the 45.6 interview lift pct suggests that interviews are a critical tool for overcoming obstacles and potentially shortening the prosecution timeline. The 1151 median days to allowance reflects the procedural duration required for successful cases to reach a conclusion in Tech Center 1600.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18936758 | EXTRACT FROM PLANT STEEPED IN ALLULOSE AND PREPARATION METHOD THEREFOR | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17920699 | BOWEL MOVEMENT IMPROVING COMPOSITION COMPRISING TENEBRIONIDAE LARVA EXTRACT | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 19558906 | METHODS AND COMPOSITIONS FOR REDUCING MUSCLE LOSS AND/OR INHIBITING SARCOPENIA ASSOCIATED WITH WEIGHT LOSS | Final Rejection | MYOS CORP. |
| 18795597 | PEST CONTROL COMPOSITIONS CONTAINED IN PLASTIC CONTAINERS | Non-Final OA | The Procter & Gamble Company |
| 18697375 | INJECTABLE BIOMATERIAL FOR DYSPHAGIA | Non-Final OA | The Regents of the University of California |
| 17795604 | COMPOSITIONS AND METHODS FOR COATING BONE GRAFTS | Non-Final OA | UNIVERSITY OF ROCHESTER |
| 17434266 | Sarcopoterium Spinosum Extract for Treating Inflammation | Final Rejection | Ariel Scientific Innovations Ltd. |
| 17621858 | USE OF A HYDRO-ALCOHOLIC EXTRACT OF EVENING PRIMROSE FOR HYDRATING SKIN AND INCREASING BARRIER FUNCTION | Non-Final OA | L'OREAL |
| 17782914 | COMPOSITIONS AND METHODS FOR PREVENTING RECURRENCE OF CANCER | Final Rejection | YALE UNIVERSITY |
| 18262798 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | Final Rejection | The Trustees of Indiana University |
| 17783276 | BACTERIA-ASSOCIATED VOLATILE ORGANIC COMPOUNDS | Final Rejection | Ramot at Tel-Aviv University Ltd. |
| 18333934 | Microspheres Containing Decellularized Donor Tissue and Their Use in Fabricating Polymeric Structures | Non-Final OA | CHILDREN'S HOSPITAL MEDICAL CENTER |
| 18557561 | DECELLULARIZED TISSUE HYDROGELS | Final Rejection | THE UNIVERSITY OF NOTTINGHAM |
| 18035138 | Tissue Customized Platelet-Rich Plasma for Optimized Skeletal Muscle, Cartilage, and Bone Healing | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 17665037 | AUTOLOGOUS THYMIC TISSUE TRANSPLANTATION | Final Rejection | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| 18368040 | ANTIMICROBIAL AGENTS DERIVED FROM BACILLUS | Final Rejection | The state of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization |
| 17798376 | COSMETIC COMPOSITION | Final Rejection | GIVAUDAN SA |
| 18387769 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | Final Rejection | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD. |
| 18456798 | COMPOSITION FOR INHIBITING WRINKLE | Final Rejection | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
| 18691547 | Method for Treating Ilk Signaling Pathway Related Diseases Using Exosome Derived from Mesenchymal Stem Cells, and Pharmaceutical Composition | Non-Final OA | SHANDONG UNIVERSITY |
| 18669730 | CANNABIS OIL EXTRACTION METHOD | Final Rejection | INSECTERGY, LLC |
| 17735956 | EDIBLE AERIAL MYCELIA AND METHODS OF MAKING THE SAME | Non-Final OA | Ecovative LLC |
| 18436797 | Methods and Compositions for Treatment of Intervertebral Disc Disease | Non-Final OA | DiscCath, LLC |
| 16301162 | PREBIOTIC COSMETIC COMPOSITIONS AND USE OF THE PREBIOTIC COSMETIC COMPOSITIONS | Final Rejection | Natura Cosméticos S.A. |
| 17906385 | METHOD FOR PRODUCING ENHANCED ANTI-INFLAMMATORY / ANTI-CATABOLIC AGENTS FROM AUTOLOGOUS PHYSIOLOGICAL FLUID | Final Rejection | Antnor Limited |
| 17427382 | METHOD FOR PRODUCING PLANT MATERIALS HAVING REDUCED VARIANCE | Final Rejection | Bionorica SE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy